Royal Bank Of Canada Imago Bio Sciences, Inc. Transaction History

Royal Bank Of Canada

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$15.03 - $35.96 $46,713 - $111,763	3,108 Added 971.25%	3,428 $123,000
Q3 2022 Nov 14, 2022	BUY	$14.15 - $19.5 $2,433 - $3,354	172 Added 116.22%	320 $5,000
Q2 2022 Aug 15, 2022	SELL	$11.81 - $20.92 $12,813 - $22,698	-1,085 Reduced 88.0%	148 $2,000
Q1 2022 May 16, 2022	SELL	$16.97 - $25.0 $11,488 - $16,925	-677 Reduced 35.45%	1,233 $24,000
Q4 2021 Feb 14, 2022	BUY	$16.22 - $29.69 $13,332 - $24,405	822 Added 75.55%	1,910 $46,000
Q3 2021 Nov 15, 2021	BUY	$16.0 - $28.84 $17,408 - $31,377	1,088 New	1,088 $21,000

19.3K

Ticker IMGO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,741,600
Description
Imago BioSciences, Inc., a clinical stage biopharmaceutical company, discovers and develops small molecule product candidates that target lysine-specific demethylase 1(LSD1), an enzyme that used in the production of blood cells in the bone marrow. Its lead product candidate is bomedemstat, which is in Phase II clinical trials for the treatment o...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.